Reports
Global Alcoholic Hepatitis Treatment Market Size, Forecast: By Type: Corticosteroids, Xanthine Derivatives, Others; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Indicators for Demand, Key Indicators for Price; Competitive Landscape; Key Trends and Developments in the Market; 2024-2032
Global Alcoholic Hepatitis Treatment Market Outlook
The global alcoholic hepatitis treatment market size will grow at a CAGR of 7% during the forecast period of 2024-2032. Globally, rising alcohol consumption has led to the alcoholic hepatitis treatment market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Alcoholic hepatitis is induced by heavy alcohol intake, leading to hepatic encephalopathy. Such levels of alcohol consumption have resulted in high mortality rates. As a result, alcoholic hepatitis needs to be treated dynamically. Vendors use this platform to sell other treatment options as well. There are several off-label drugs and corticosteroids in the market. Off-label treatments are used as a first-line treatment for alcoholic hepatitis inflammation and corticosteroids. Due to the lack of curative medicines available in the industry, the demand for these medications is expected to increase.
Properties and Applications
Alcoholic hepatitis is caused by the excessive intake of alcohol, also known as hepatitis, inflammation of the liver. It is usually found in combination with fatty liver, an early stage of alcoholic liver disease, and can contribute to fibrosis development, leading to cirrhosis.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The alcoholic hepatitis treatment market can be divided on the basis of segments like types and regions.
The industry can be broadly categorised on the basis of type into:
- Corticosteroids
- Xanthine Derivatives
- Others
The EMR report looks into the regional markets for alcoholic hepatitis treatment like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific regions.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The main factors resulting in the growth of the global hepatitis treatment market is the development of new strategies and viable treatment options for alcoholic hepatitis management. Presently, there are no effective treatments available for serious alcoholic hepatitis, and this condition is being capitalized by vendors. In the forthcoming years, there will be tremendous growth potential for vendors. Vendors focus on the development of innovative therapies as they prove to be highly effective. Several experimental drugs are undergoing clinical trials, which during the forecast period, will have a positive impact on the industry growth for hepatitis treatment.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global alcoholic hepatitis treatment market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Sun Pharmaceutical Industries Limited
- Gilead Sciences, Inc. (NASDAQ: GILD)
- Teva Pharmaceutical Industries Ltd.
- Saneca Pharmaceuticals a.s.
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Region |
| Breakup by Type | Corticosteroids, Xanthine Derivatives, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Sun Pharmaceutical Industries Limited, Gilead Sciences, Inc. (NASDAQ: GILD), Teva Pharmaceutical Industries Ltd., Saneca Pharmaceuticals a.s., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Alcoholic Hepatitis Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Alcoholic Hepatitis Treatment Historical Market (2018-2023)
8.3 Global Alcoholic Hepatitis Treatment Market Forecast (2024-2032)
8.4 Global Alcoholic Hepatitis Treatment Market by Type
8.4.1 Corticosteroids
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Xanthine Derivatives
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Others
8.5 Global Alcoholic Hepatitis Treatment Market by Region
8.5.1 North America
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Europe
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Asia Pacific
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Latin America
8.5.4.1 Historical Trend (2018-2023)
8.5.4.2 Forecast Trend (2024-2032)
8.5.5 Middle East and Africa
8.5.5.1 Historical Trend (2018-2023)
8.5.5.2 Forecast Trend (2024-2032)
9 North America Alcoholic Hepatitis Treatment Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Alcoholic Hepatitis Treatment Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Italy
10.5.1 Historical Trend (2018-2023)
10.5.2 Forecast Trend (2024-2032)
10.6 Others
11 Asia Pacific Alcoholic Hepatitis Treatment Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Alcoholic Hepatitis Treatment Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Alcoholic Hepatitis Treatment Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Sun Pharmaceutical Industries Limited
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Gilead Sciences, Inc. (NASDAQ: GILD)
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Teva Pharmaceutical Industries Ltd.
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Saneca Pharmaceuticals a.s.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Alcoholic Hepatitis Treatment Market: Key Industry Highlights, 2018 and 2032
2. Global Alcoholic Hepatitis Treatment Historical Market: Breakup by Type (USD Million), 2018-2023
3. Global Alcoholic Hepatitis Treatment Market Forecast: Breakup by Type (USD Million), 2024-2032
4. Global Alcoholic Hepatitis Treatment Historical Market: Breakup by Region (USD Million), 2018-2023
5. Global Alcoholic Hepatitis Treatment Market Forecast: Breakup by Region (USD Million), 2024-2032
6. North America Alcoholic Hepatitis Treatment Historical Market: Breakup by Country (USD Million), 2018-2023
7. North America Alcoholic Hepatitis Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
8. Europe Alcoholic Hepatitis Treatment Historical Market: Breakup by Country (USD Million), 2018-2023
9. Europe Alcoholic Hepatitis Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
10. Asia Pacific Alcoholic Hepatitis Treatment Historical Market: Breakup by Country (USD Million), 2018-2023
11. Asia Pacific Alcoholic Hepatitis Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Latin America Alcoholic Hepatitis Treatment Historical Market: Breakup by Country (USD Million), 2018-2023
13. Latin America Alcoholic Hepatitis Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Middle East and Africa Alcoholic Hepatitis Treatment Historical Market: Breakup by Country (USD Million), 2018-2023
15. Middle East and Africa Alcoholic Hepatitis Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Global Alcoholic Hepatitis Treatment Market Structure
Key Questions Answered in the Report
The global alcoholic hepatitis treatment market is projected to grow at a CAGR of 7% between 2024 and 2032.
The major drivers of the industry, such as the shifting consumer preferences and increased consumption of alcohol, rising disposable incomes, growing availability of off-label drugs and corticosteroids, and the increased government investments in the development of the healthcare sector, are expected to aid the market growth.
The key market trends guiding the growth of the industry include the growing focus on research and development activities by the major players and rapid technological advancements.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Corticosteroids and xanthine derivatives, among others, are the leading alcoholic hepatitis treatment types in the industry.
The major players in the industry are Sun Pharmaceutical Industries Limited, Gilead Sciences, Inc. (NASDAQ: GILD), Teva Pharmaceutical Industries Ltd., and Saneca Pharmaceuticals a.s., among others.
Analyst Review
The global alcoholic hepatitis treatment market is being driven by the development of the medical sector and the growing incidences of alcoholic hepatitis across the globe. Aided by the increasing complexity of clinical trials and the growing R&D activities, the market is expected to witness a robust growth in the forecast period of 2024-2032, growing at a CAGR of 7%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on types, the industry can be segmented into corticosteroids and xanthine derivatives, among others. The major regional markets for alcoholic hepatitis treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Sun Pharmaceutical Industries Limited, Gilead Sciences, Inc. (NASDAQ: GILD), Teva Pharmaceutical Industries Ltd., and Saneca Pharmaceuticals a.s., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$2799
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER